Risk assessment in regulatory policy making for human and veterinary public health

Journal of Clinical Pharmacology

Volumn 42, Issue 8, 2002, Pages 846-866

  Lathers, Claire M ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; VETERINARY DRUG;

ANTIBIOTIC RESISTANCE; ENTEROCOCCUS FAECIUM; FOOD AND DRUG ADMINISTRATION; FOOD CONTAMINATION; FOOD INDUSTRY; FOOD SAFETY; HEALTH CARE POLICY; HUMAN; MONTE CARLO METHOD; MULTIDRUG RESISTANCE; NONHUMAN; PROBABILITY; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; UNITED STATES; VETERINARY MEDICINE; ANIMAL; FOOD HANDLING; MANAGEMENT; METHODOLOGY; STANDARD;

ANIMAL; ANTIBIOTICS; DRUG RESISTANCE, BACTERIAL; FOOD CONTAMINATION; FOOD HANDLING; HUMAN; POLICY MAKING; PUBLIC HEALTH; RISK ASSESSMENT; VETERINARY DRUGS; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0035997140     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127002401102768     Document Type: Review

References (129)

1. Human health risk assessment: A historical overview and alternative paths forward
2. Tourism and emerging and re-emerging infectious disease in the Americas: What physicians must remember for patient diagnosis and care
3. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations
4. A multistate outbreak of Escherichia coli O157-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: The Washington experience
5. Massive outbreak in waterborne Cryptosporidium infection in Milwaukee, Wisconsin: Recurrence of illness and risk of secondary transmission
6. Genetic identification of a Hantavirus associated with an outbreak of acute respiratory illness
7. Cholera in Piura, Peru: A modern urban epidemic
8. Vibrio cholerae O139 Bengal: Emergence of a new epidemic strain of cholera
9. Plague in India: Lessons for public health everywhere
10. Dengue type 3 infection-Nicaragua and Panama, October-November 1994
11. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with acquired immunodeficiency syndrome
12. Noscomial enterococci resistant to vancomycin-United States, 1989-1993
13. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
14. Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens
15. Foods and microbiological risks
16. Risk analysis and meat hygiene
17. Preliminary estimates of costs of foodborne disease in Canada and costs to reduce salmonellosis
18. Epidemiology of foodborne illness: North America
19. Trends in antimicrobial drug prescribing among office-based physicians in the United States
20. Food-related illness and death in the United States
21. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: Implications for the use of fluoroquinolones in food animals
22. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT14 infections in the United States
23. Changes in antimicrobial resistance in Salmonella enterica serovar typhimurium
24. New goldfish model to evaluate pharmacokinetic and pharmacodynamic effects of drugs for motion sickness in different gravity loads
25. Risk assessment and biological mechanisms: Lessons learned, future opportunities
26. Clinical pharmacology of antimicrobial use in humans and animals
27. Overcoming antimicrobial resistance by targeting resistance mechanisms
28. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
29. Clinical pharmacology of topirimate vs lamotrigine vs phenobarbital: Comparison of efficacy and side effects using odds ratios
30. Association of increased recipient ability for R factors and reduced virulence among variants of Salmonella choleraesuis varr
31. Antibiotics in animal feeds
32. Editorial: Infectious drug resistance
33. Nutritional effects of antibiotics
34. Indirect consequences of low-level use of antimicrobial agents in animal feeds
35. Effectiveness of antibiotics in broiler feeds
36. Chick growth response to dietary antibiotics remains undiminished after 30 years
37. Bursal, intestinal, and spleen weights and antibody response of chicks fed subtherapeutic levels of dietary antibiotics
38. Broiler chick growth response to antibiotics 1981-1982
39. High frequency of antimicrobial resistance in human fecal flora
40. Antibiotic resistance from food
41. Resistant bacteria in the normal human flora
42. Antibiotic residues and drug resistance in human intestinal flora
43. Escherichia coli in the fecal flora of man
44. Fate of ingested Escherichia coli in normal persons
45. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm
46. Microbiological safety of irradiated foods
47. The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli
48. Current status of antibiotic resistance in animal production
49. The control of microbial diseases in animals: Alternatives to the use of antibiotics
50. The need for a veterinary antibiotic policy
51. Use of molecular subtyping in surveillance for Salmonella enterica serotype typhimurium
52. Changes in antimicrobial resistance among Salmonella enterica serovar typhimurium isolates from humans and cattle in the north-western United States, 1982-1997
53. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe
54. Food safety and public health
55. Evaluating the safety of food constituents
56. FDA's priority-based assessment of food additives
57. Monitoring adverse reactions to food additives in the U.S. Food and Drug Administration
58. Methods and approaches used by FDA to evaluate the safety of food packaging materials
59. Public health aspects of antibiotic resistance monitoring in the USA
60. Phage type and antimicrobial resistance trends among human salmonella serotype typhimurium isolates in NARMS 1997-1998: Continued dominance of DT-104 R-type ACSSuT
61. The isolation of antibiotic-resistant salmonella from retail ground meats
62. Historical perspective on risk assessment in the federal government
63. Risk assessment, the environment, and public health
64. Scientific bases for identification of potential carcinogens and estimation of risks
65. New methodology for assessing the probability of contaminating Mars
66. A general framework illustrating an approach to quantitative microbial food safety risk assessment
67. Uncertainty in health risk assessments
68. Risk assessment approaches and methods
69. Handling hazards
70. Perception of risk
71. Risk assessment in environmental policy-making
72. Endocrine disruptors: A new scientific role for clinical pharmacologists? Impact on human health, wildlife and the environment
73. Quantitative microbiological risk assessment: Principles applied to determining the comparative risk of salmonellosis from chicken products
74. Human interindividual variability in parameters related to health risks
75. Modeling applications
76. Recommended distributions for exposure factors frequently used in health risk assessment
77. Mathematical models in decision analysis
78. Using Monte Carlo simulations in public health risk assessments: Estimating and presenting full distributions of risk
79. Risk assessment and predictive microbiology
80. Simulation modeling for microbial risk assessment
81. Measures of compounding conservatism in probabilistic risk assessment
82. Exposure assessment: Then, now, and quantum leaps in the future
83. Short communication: Selecting input distributions for use in Monte Carlo simulations
84. Principles of good practice for the use of Monte Carlo technique in human health and ecological risk assessments
85. Monte Carlo techniques for quantitative uncertainty analysis in public health risk assessments
86. The application of quantitative risk assessment to microbial food safety
87. Antimicrobial resistance documents available
88. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future
89. Modeling the impact of virginiamycin resistance in Enteroccus faecium in animals with the recently approved human antimicrobial, Synercid
90. Role of veterinary medicine in public health: Antibiotic use in food animals and humans and the effect on evolution of antibacterial resistance
91. Lessons learned from the past: A guide for the future of clinical pharmacology in the 21st century
92. Evaluation of student achievement and educational outcomes
93. Web-based sharing of cutting-edge teaching strategies
94. Development of innovative teaching materials: Clinical pharmacology problem-solving (CPPS) units: Comparison with patient-oriented problem-solving units and problem-based learning - A 10-year review
95. Educational issues in clinical pharmacology: Who are our audiences and what are their specialized needs? One specialized need: To understand the role of veterinary medicine in public health
96. Limitations, definitions, principles and methods of risk analysis
97. Organizational theory and the stages of risk communication
98. Antimicrobial use in animal feed-time to stop
99. Development of a standard soil-to-skin adherence probability density function for use in Monte Carlo analyses of dermal exposure
100. Mechanistic modelling and risk assessment
101. MBS: A model for risk benefit analysis of breast cancer screening
102. A probabilistic framework for the reference dose (probabilistic RfD)
103. Modeling benzene pharmacokinetics across three sets of animal data: Parametric sensitivity and risk implications
104. The application of risk assessment methods in making veterinary public health and animal health decisions
105. Threshold of estimated toxicity for regulation of indirect food additives
106. Food and Drug Administration risk assessment: Process and toxicologic pathology
107. Approaches to limiting emergence of antimicrobial resistance in bacteria in human populations
108. Antibiotic resistance: An ecological imbalance
109. Quantitative risk assessment for Escherichia coli O157:H7 in ground beef hamburgers
110. Research to strengthen the scientific basis for health risk assessment: A survey of the context and rationale for mechanistically based methods and models